 NEW YORK, Feb. 10, 2022 GLOBE NEWSWIRE -- Tiziana Life Sciences Ltd Nasdaq: TLSA Tiziana or the Company, a biotechnology company enabling breakthrough immunotherapies via novel routes of drug delivery, announced today that Dr Kunwar Shailubhai, Chief Executive Officer and Chief Scientific Officer, will be presenting at the upcoming 2022 BIO CEO Investor Conference being held at the Marriott Marquis in NYC on February 14-15 and virtually through the 17th. 